HLA-C and neoplasm: Phagocytosis as a consequence of Fc-receptor engagement can result in preferential presentation of tumour-associated antigens by MHC class-I rather than MHC class-II, potentially activating CD8-positive effector T cells with tumour-antigen specificity (reviewed by Desjarlais et al, 2007).